Carol Nilsson (Former)
21 – 30 of 58
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Discovery of a novel B-Raf fusion protein related to c-Met drug resistance
(
- Contribution to journal › Article
- 2010
-
Mark
Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo
2010) In Proceedings of the National Academy of Sciences of the United States of America 107(28). p.51-12646(
- Contribution to journal › Article
-
Mark
Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation
(
- Contribution to journal › Article
-
Mark
Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network : an initial study in GSC11 glioblastoma stem cells
(
- Contribution to journal › Article
-
Mark
Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecan
(
- Contribution to journal › Article
- 2008
-
Mark
Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals
(
- Contribution to journal › Article
- 2007
-
Mark
Identification of single and double sites of phosphorylation by ECD FT-ICR/MS in peptides related to the phosphorylation site domain of the myristoylated alanine-rich C kinase protein
(
- Contribution to journal › Article
-
Mark
Method for lipidomic analysis : p53 expression modulation of sulfatide, ganglioside, and phospholipid composition of U87 MG glioblastoma cells
(
- Contribution to journal › Article
-
Mark
Fourier transform ion cyclotron resonance : state of the art
(
- Contribution to journal › Scientific review
-
Mark
Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expression
(
- Contribution to journal › Article